Incyte to Report First Quarter Financial Results on April 30

WILMINGTON, Del.--()--Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its first quarter 2015 financial results conference call for 8:00 a.m. ET on Thursday, April 30, 2015. The schedule for the press release and conference call is as follows:

                   
• Q1 2015 Press Release: April 30, 2015 at 7:00 a.m. ET
• Q1 2015 Conference Call:

April 30, 2015 at 8:00 a.m. ET

• Domestic Dial-In Number: 877-407-8037
• International Dial-In Number: 201-689-8037
• Conference ID Number: 13604399
 

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13604399.

The conference call will also be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics, primarily for oncology. For additional information on Incyte, please visit the Company's web site at www.incyte.com.

Contacts

Incyte Corporation
Michael Booth, DPhil
Vice President, Investor Relations
302.498.5914

Contacts

Incyte Corporation
Michael Booth, DPhil
Vice President, Investor Relations
302.498.5914